If you made any changes in Pure these will be visible here soon.

Personal profile


Reader in Synthetic Biology and Quantitative Genomics, Division of Evolution and Genomic Sciences, Faculty of Biology, Medicine and Health at Manchester University. Principle Investigator at the Manchester Institute of Biotechnology.  Philip is also Business Engagement Lead for the Division of Evolution and Genomic Sciences, Postgraduate Research Tutor and Biomed Sciences Academic Tutor and Academic Advisor. 

Research interests

Philip Day is Reader in Quantitative Analytical Genomics at Manchester University, Director of the Quantitative Molecular Medicine Group and Principle Investigator at the Manchester Institute of Biotechnology, and a member of the Centre for Epidemiology and CIGMR, at the Medical Faculty. He currently is developing synthetic biology and chemical biology approaches to directed evolution of novel proteins and aptamers for biomedical applications. These are used in combination with expertise for building integrated pathogenesis models of CML. Other closely related studies concern the enhanced uptake of anti-cancer drugs through membrane associated transporters, and Philip maintains an academic interest in the biological significance of heterogeneity. 

Methodological knowledge


molecular biology

Assay development

sample preparation and handling

Single cell analysis, homogeneous sample handling

Aptamer development

Systems biology/medicine

Chemical biology

Synthetic biology

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

External positions

Thought, Leadership & Innovation Fellow, TLI Foundation, VA, USA

1 Jun 2022 → …

Honorary Professor, University of Cape Town

1 Jan 2021 → …

Honorary Professor, UC Berkeley

1 Apr 2019 → …

Visiting Professor, UCI, Biomedical Engineering


Areas of expertise

  • QD Chemistry
  • RZ Other systems of medicine
  • TP Chemical technology

Research Beacons, Institutes and Platforms

  • Advanced materials
  • Cancer
  • Biotechnology
  • Digital Futures
  • Dementia@Manchester
  • Manchester Precision Medicine Institute
  • Christabel Pankhurst Institute
  • Manchester Institute of Biotechnology


Dive into the research topics where Philip Day is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles